Even in states that allow coverage, requirements and access can change frequently
Tummy Troubles Are Common Many people have stomach problems when they first start GLP1 medicines: Nausea Vomiting Diarrhoea Constipation Bloating or a full feeling These issues are more common when the dose increases too rapidly
The study completed in November 2024 demonstrating statistically significant efficacy with UC clinical remission rates of 36% (450mg) and 48% (900mg) versus 20% placebo, favorable safety profile with lower adverse event rates than placebo, and led to a long-term extension study (NCT05668013) providing 44-week maintenance therapy for responders and re-induction for non-responders to evaluate sustained efficacy and corticosteroid-free remission (77, 78)
Generally, more tirzepatide-treated participants achieved the weight reduction targets of 5, 10, 15, 20 and 25% compared with placebo-treated participants, regardless of disease duration
Start Your Weight Loss Treatment Today If your main interest was Ozempic for weight loss, you now know there are optimal, specifically-designed options at your disposal
Where required, we facilitate COA availability and support SDS/MSDS requests
